This Month
Regal Fund backs drone parts manufacturer’s pre-IPO raising
KTEK Systems is a supplier of airframes for combat drones to defence manufacturers in the US, European Union and Israel.
Meet the small Northern Rivers fund with 7pc of Firmus
Tectonic, a vehicle started by a trio of former Partners Group operatives, is an earlier backer of the runaway artificial intelligence infrastructure start-up.
Dud deals, dud timing: Late IPO flops spoil a momentum-building year
The three most recent floats to raise $100 million or more to list have performed terribly, tarnishing a mid-year resurgence.
London’s stock exchange struggles for relevance as IPOs dry up
Stock markets around the world are drying up as companies tap widening and deepening pools of private capital, consolidate, delist or rationalise dual listings.
Sharon AI pre-IPO raising upsized; seeks $2b debt
Allocation emails have gone out to bidders saying the deal is done and has been upsized to $150 million following strong demand.
Ellerston-backed defence play charts course for the ASX; banks appointed
The Whiskey Project Group has appointed Morgans Financial and Canaccord Genuity as joint lead managers for the IPO.
Massive SpaceX IPO would make Musk a nearly instant trillionaire
Elon Musk could become the world’s first trillionaire, more than doubling his wealth, if SpaceX goes public next year.
Quadrant presents $1b revenue Amart-Freedom IPO; pitch decks land
Quadrant reckons there’s an opportunity to optimise Freedom’s performance by deploying “the Amart playbook” and co-locating stores.
Ground control to Elon Musk: SpaceX’s $2.2trn IPO plan is pure AI hype
The planned IPO of SpaceX relies on Elon Musk putting data centres in space. No, seriously.
Sharon AI launches $100m capital raising ahead of 2026 IPO
Sharon AI also has terms in place for a debt facility with a large global bank for $US152.4 million ($229 million), bringing the total raise to $US217.4 million.
QPE’s Amart Furniture kicks off early meetings for IPO
Should it succeed, it would join a line-up of listed home retailers including Nick Scali, Adairs, Temple and Webster and Joyce Corporation.
Saluda Medical shares sink in worst ASX debut in decades
Former Cochlear boss Catherine Livingstone sits on the board of the US-based company which lost more than 50 pct of its value on the first day of trading.
Macquarie blows whistle on passive funds, says M&A rules are changing
Index and quant ownership of Australian shares has more than doubled in the past 15 years, bringing unintended consequences.
Sharon AI poised to launch $100m pre-IPO round; eyes March IPO
Sharon AI is moving swiftly ahead with its pre-IPO funding round and making a beeline for the ASX in the new year.
Canadian Securities Exchange flags interest in Cboe Australia
CNSX chief Richard Carleton says the Canadian exchange is weighing a bid for Cboe’s exchanges, potentially offering tougher competition for the ASX.
Saluda Medical set for $775m ASX debut
With links to Cochlear, the US-based med-tech company has global ambitions for its spinal cord stimulator technology.
Metal powders manufacturer 6K Additive upsizes IPO
The Pittsburgh-headquartered materials play is set to debut on the ASX with a $267 million market capitalisation.
Cochlear-backed Epiminder overcomes ASX turmoil to hit the boards
The biotech specialises in epilepsy monitoring and prevention, but saw its shares slump on debut. The company says it is focused on its long-term potential.
November
Aussie firms return to Hong Kong as IPO market booms
Jason Chang, the Australian Chamber of Commerce in Hong Kong’s new chair, says two of the world’s biggest IPOs demonstrate the strength of the Hong Kong market.
The pharmacist from Fitzroy who amassed a $7b fortune with Chemist Warehouse
The pharmacists who’ve been made rich by following Chemist Warehouse’s Mario Verrocchi call him The Godfather. He’s told them to get back to work.